Auxo Firm Directory · Independent Research Profile

B Capital United States Asia

B Capital describes a multistage investment approach supporting companies from seed through market leadership. Its stated focus areas are Technology/AI, Healthcare, and Energy, with a global footprint spanning the United States and Asia and portfolio classifications across North America, Asia, Europe, and the Middle East.

Key takeaway

What stands out about B Capital United States Asia

B Capital publicly presents itself as a multistage investor for early- to late-stage companies in Technology/AI, Healthcare, and Energy. Its growth-to-late-stage support includes capital advisory, strategy and business development, and people and organizational support. The cited official Our Focus page does not state a universal minimum investment amount, revenue range, EBITDA threshold, valuation range, or mandatory company-size criterion.[1][2][3][4][5][6][9]

What types of capital does B Capital United States Asia provide?

B Capital is an investment firm led by Eduardo Saverin, Raj Ganguly, and Howard Morgan. It describes its mandate as supporting early- to late-stage innovators in Technology, Healthcare, Energy & Resilience, and related areas.

The firm describes a multistage approach supporting companies from seed through market leadership. For growth-to-late-stage companies, its stated support includes capital advisory, strategy and business development, and people and organizational support.[1][3]

B Capital publicly describes multistage investment support from seed through market leadership. Its public materials identify dedicated stage-based funds and state that the firm had more than $9 billion in assets under management in an official release dated October 23, 2025.

The cited materials do not establish a complete list of fund products or the terms applicable to a particular company.[3][5]

B Capital identifies San Francisco as its headquarters and Singapore as a regional headquarters. It also lists offices in Doha, Los Angeles, New York, Austin, and Hong Kong.

Its official portfolio page classifies portfolio companies across North America, Asia, Europe, and the Middle East.[1][4]

Public size / criteria information
A B Capital official news release dated October 23, 2025 stated that the firm had more than $9 billion in assets under management and dedicated stage-based funds. The cited official Our Focus page does not state a universal minimum investment amount, revenue range, EBITDA threshold, valuation range, or mandatory company-size criterion.[5]

What should a business owner evaluate before seeking capital from B Capital United States Asia?

A company evaluating B Capital should confirm which fund and strategy would evaluate the opportunity, the applicable investment size and ownership expectations, and whether the proposed position would be minority, preferred, or control. The public materials cited for this profile do not establish those company-specific terms.

It is also appropriate to clarify governance, board, information, liquidation-preference, follow-on, investment-horizon, exit, conflict, fee, expense, and indemnity provisions for the applicable strategy. The cited public materials establish B Capital’s multistage model and support resources but do not establish these terms.[3][4][9]

01

Which B Capital fund and strategy would evaluate the company

B Capital describes a multistage approach and dedicated stage-based funds, while the cited public materials do not identify the fund or strategy applicable to a particular company.[3][5]
02

What are the current minimum and target investment sizes and ownership expectations

The cited official Our Focus page does not state a universal minimum investment amount, and the cited portfolio page does not publish ownership percentages or investment amounts.[3][4]
03

Does the firm seek minority, preferred, or control positions

The cited public materials describe multistage investment support but do not establish the position type sought for a particular company.[3][4]

What companies and financing uses does B Capital United States Asia focus on?

B Capital identifies Technology/AI, Healthcare, and Energy as focus areas and describes support for companies across multiple stages, from seed through market leadership.

The cited official Our Focus page does not state a universal minimum investment amount, revenue range, EBITDA threshold, valuation range, or mandatory company-size criterion.[3]

The public materials describe investment support and, for growth-to-late-stage companies, capital advisory, strategy and business development, and people and organizational support. They do not establish a defined list of transaction uses for a particular financing.[3]

B Capital identifies Technology/AI, Healthcare, and Energy as focus areas. Its technology sub-focuses include Enterprise and FinTech.

Its healthcare focus includes Healthcare IT and SaaS, Digital Healthcare, Biotechnology and Bio-IT, and healthcare insurance and payment models.[3]

B Capital states that its value-add approach combines a global network, internal advisory resources, a strategic partnership with Boston Consulting Group, and an AI engineering team supporting the firm and its portfolio.

B Capital also states that BCG advisors are not B Capital partners or employees, and that BCG does not participate in B Capital investment decision-making or day-to-day management.[5][12]

B Capital announced an investment in Flourish Health on July 30, 2026, and an investment in Cadence on June 25, 2026.

In an official investment article dated July 6, 2026, B Capital announced that it led the $53M Series C in SolarSquare. Its official News and Insights archive also lists investments in Star Catcher on June 9, 2026; Lunar Energy on March 19, 2026; Code Metal on February 19, 2026; JetZero on February 17, 2026; and Fervo Energy on January 22, 2026.[6][7][8][9]

What does B Capital United States Asia disclose about capital products and terms?

An SEC-filed Form ADV identifies B CAPITAL GROUP MANAGEMENT, L.P. as the legal name and B CAPITAL as the primary business name. The filing reports CRD number 287986 and SEC file number 802-110185 in an exempt reporting adviser filing.

An SEC Form D identifies B Capital Opportunities Fund II, L.P. as a Cayman Islands exempted limited partnership classified as a pooled investment fund and venture capital fund. The filing identifies Section 3(c)(7) of the Investment Company Act as an exemption claimed for the offering.[2][10]

The cited official Our Focus page does not state a universal minimum investment amount, revenue range, EBITDA threshold, valuation range, or mandatory company-size criterion.

The cited official portfolio page does not publish transaction consideration, ownership percentages, investment amounts, or complete acquisition and exit dates for listed companies. The cited official News and Insights archive lists dated investment announcements but does not itself disclose complete transaction consideration, ownership acquired, or fund-level allocation for those investments.[3][4][9]

Questions to ask before seeking capital from B Capital United States Asia

Which B Capital fund and strategy would evaluate the company?
B Capital describes a multistage approach and dedicated stage-based funds, while the cited public materials do not identify the fund or strategy applicable to a particular company.[3][5]
What are the current minimum and target investment sizes and ownership expectations?
The cited official Our Focus page does not state a universal minimum investment amount, and the cited portfolio page does not publish ownership percentages or investment amounts.[3][4]
Does the firm seek minority, preferred, or control positions?
The cited public materials describe multistage investment support but do not establish the position type sought for a particular company.[3][4]
What governance, board, information, liquidation-preference, and follow-on rights are customary?
The cited portfolio and News and Insights sources do not publish complete transaction terms or ownership acquired, so these proposed rights should be confirmed directly for the applicable strategy.[4][6][9]
What is the expected investment horizon and exit approach for the applicable strategy?
The cited public materials describe support from seed through market leadership but do not establish an investment horizon or exit approach for a particular strategy.[3][4]
Which internal platform resources and BCG-related support are available to the company?
B Capital describes internal advisory resources, an AI engineering team, a global network, and a strategic partnership with BCG; it also states that BCG advisors are not B Capital partners or employees and do not participate in investment decisions or day-to-day management.[5][12]
How are conflicts handled where B Capital or affiliated funds hold positions in adjacent companies?
The cited public materials identify named active and exited portfolio companies but do not establish a conflict-management policy for adjacent holdings.[4]
What transaction terms, fees, expenses, and indemnities would apply?
The cited official portfolio, Flourish Health, and News and Insights sources do not disclose complete transaction terms, and the cited News and Insights archive does not disclose complete consideration or fund-level allocation.[6][9]

Sources & research notes

Public-source research
  1. Official website / firm overview
  2. SEC filing / regulatory record
  3. Services / capabilities
  4. Geography / market coverage
  5. Transaction size / criteria
  6. Transaction / portfolio evidence
  7. Transaction / portfolio evidence
  8. Transaction / portfolio evidence
  9. Transaction / portfolio evidence
  10. SEC filing / regulatory record
  11. Structure / regulatory context
  12. Public Process
Prepared and reviewed by: Auxo Capital AdvisorsEvidence standard: Public-source verification

How this profile was researched

Auxo profiles are prepared from publicly available primary and authoritative sources and reviewed for entity identity, factual support and disclosure consistency. When a fact cannot be supported by the reviewed public record, the profile identifies it as something to confirm directly rather than inferring it.

Independent profile & regulatory context

Independent research profile

This profile was prepared by Auxo Capital Advisors from publicly available information believed to be reliable and is provided solely for informational and educational purposes. It is not an endorsement, recommendation, ranking, solicitation, or representation regarding the profiled firm, its services, qualifications, transaction experience, regulatory status, financial condition, or suitability for any particular person, company, transaction, or investment.

Information obtained from third-party and public sources may be incomplete, inaccurate, outdated, or subject to change, and Auxo Capital Advisors makes no representation or warranty, express or implied, as to its accuracy, completeness, or timeliness. Readers should conduct their own independent diligence and consult appropriate professional advisers before engaging any advisor, intermediary, investor, lender, acquirer, or other transaction counterparty.

Broker-dealer and securities disclosure

Auxo Capital Advisors is an affiliate of Weild & Co., Member FINRA | SIPC. Securities-related activities and securities transactions are conducted through Weild & Co.

Nothing contained on this page constitutes an offer to sell, an offer to purchase, or a solicitation of an offer to buy or sell any security, investment product, or financial instrument. Nothing on this page constitutes investment advice, a recommendation regarding any security, or a recommendation to enter into any transaction with the profiled firm or any other party.

Any securities transaction, capital-raising engagement, investment-banking engagement, or other securities-related activity involving Auxo Capital Advisors or Weild & Co. is subject to applicable regulatory requirements, internal review and approval, suitability and other applicable diligence requirements, and the terms of a separate written engagement or transaction agreement, as applicable.

Inclusion of a third-party firm in this directory does not imply affiliation with, sponsorship by, endorsement by, or any other relationship with Auxo Capital Advisors or Weild & Co. unless expressly stated otherwise.